GSK Leaving Pennsylvania Emergen-C Plant, Adding Voltaren To US OTC Line

 
• By Malcolm Spicer

UK pharma announced that in 2021 it will close its manufacturing facility in Carlisle, PA, where around 260 people are employed making the Emergen-C line. It will move the manufacturing to its Guayama, PR, facility.

GSK Carlisle
GSK is phasing out production at its Carlisle, PA, production facility by mid-2021 and will full exit the site by the end of that year.

More from Strategy

More from Business